Cartesian Therapeutics, Inc. — Director's Dealing 2019

Mar 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-03-25

Reporting Person: Kogan Elona Esq. (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-25	Common Stock	A	100000	—	Acquired	100000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-25	Stock Option (Right to Buy)	$2.29	A	400000	Acquired	2029-03-24	Common Stock (400000.0)	Direct

Footnotes

F1: Represents shares underlying Restricted Stock Unit awards, which vest, and the underlying shares become issuable, upon achievement of specified performance goals.

F2: This option vests as to 25% on March 20, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.